CY1107538T1 - Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη - Google Patents

Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη

Info

Publication number
CY1107538T1
CY1107538T1 CY20061101522T CY061101522T CY1107538T1 CY 1107538 T1 CY1107538 T1 CY 1107538T1 CY 20061101522 T CY20061101522 T CY 20061101522T CY 061101522 T CY061101522 T CY 061101522T CY 1107538 T1 CY1107538 T1 CY 1107538T1
Authority
CY
Cyprus
Prior art keywords
advantaged
vaccine
mycoplasma
strain
milk
Prior art date
Application number
CY20061101522T
Other languages
English (en)
Inventor
Robin Ashley John Nicholas
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1107538T1 publication Critical patent/CY1107538T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Περιγράφεται ένα στέλεχος του Mycoplasma, το οποίο αποτελεί έναν αιτιολογικό παράγοντα της πνευμονίας των βοοειδών, το οποίο έχει αδρανοποιηθεί με επεξεργασία με έναν παράγοντα, ο οποίος διασπά τις κυτταρικές μεμβράνες, όπως είναι η σαπωνίνη. Προτιμότερα, το στέλεχος είναι το Mycoplasma bovis ή το Mycoplasma mycoides υποείδος mycoides SC. Τα στελέχη αυτά μπορούν να χρησιμοποιηθούν ως εμβόλια. Περιγράφονται και αξιώνονται επίσης, κτηνιατρικές συνθέσεις, μέθοδοι παρασκευής αυτών και η χρήση τους στην προφύλαξη.
CY20061101522T 2001-05-03 2006-10-24 Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη CY1107538T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0110851.3A GB0110851D0 (en) 2001-05-03 2001-05-03 Vaccine
EP02720307A EP1387693B1 (en) 2001-05-03 2002-05-03 Saponin inactivated mycoplasma vaccine

Publications (1)

Publication Number Publication Date
CY1107538T1 true CY1107538T1 (el) 2013-03-13

Family

ID=9913953

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101522T CY1107538T1 (el) 2001-05-03 2006-10-24 Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη

Country Status (12)

Country Link
US (1) US20040170652A1 (el)
EP (1) EP1387693B1 (el)
AT (1) ATE335505T1 (el)
CA (1) CA2445997A1 (el)
CY (1) CY1107538T1 (el)
DE (1) DE60213785T2 (el)
DK (1) DK1387693T3 (el)
ES (1) ES2269672T3 (el)
GB (1) GB0110851D0 (el)
MX (1) MXPA03010053A (el)
PT (1) PT1387693E (el)
WO (1) WO2002089838A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US20070009545A1 (en) 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
CN101721694B (zh) * 2009-11-07 2013-01-30 中国农业科学院兰州兽医研究所 山羊支原体肺炎二联灭活疫苗及其制备方法
LT3334454T (lt) 2015-08-14 2022-12-27 Zoetis Services Llc Mycoplasma bovis kompozicijos
CN110551634A (zh) * 2019-09-04 2019-12-10 中国农业科学院兰州兽医研究所 一种山羊支原体山羊肺炎亚种分离培养方法
CN110551653A (zh) * 2019-09-04 2019-12-10 中国农业科学院兰州兽医研究所 一种无血清制备牛支原体抗原的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540568B2 (el) * 1972-10-05 1980-10-18
GB9108682D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Production of vaccines
WO1995022314A1 (en) * 1994-02-18 1995-08-24 Innovac Co. Inoculation of animals with dried, pelleted biological materials
US7943153B1 (en) * 1999-11-08 2011-05-17 Biomune Vaccines for Mycoplasma bovis and methods of use
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
WO2002089838A1 (en) 2002-11-14
MXPA03010053A (es) 2004-03-09
ATE335505T1 (de) 2006-09-15
US20040170652A1 (en) 2004-09-02
DK1387693T3 (da) 2006-11-13
EP1387693B1 (en) 2006-08-09
PT1387693E (pt) 2006-12-29
DE60213785T2 (de) 2007-08-23
ES2269672T3 (es) 2007-04-01
EP1387693A1 (en) 2004-02-11
CA2445997A1 (en) 2002-11-14
DE60213785D1 (de) 2006-09-21
GB0110851D0 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
CY1107538T1 (el) Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη
MX2021015775A (es) Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos.
BR112018007812A2 (pt) polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica.
EP3616716A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CO6260103A2 (es) Composiciones que comprenden antigenos neumococidos
BR112018004242A2 (pt) composições de vacina que possuem estabilidade e imunogenicidade aumentadas
BRPI1013780B8 (pt) Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica
CO6460761A2 (es) Vacuna viva modificada de mycoplasma bovis mejorada, métodos de producción de vacunas vivas de mycoplasma bovis, vacunas de combinación y métodos de tratamiento
DK1326633T3 (da) Sammensætning omfattende immunogene mikropartikler
MX2020008454A (es) Composicion inmunogenica que comprende antigenos estafilococicos.
MX2023007395A (es) Vacunas del virus de la peste porcina africana (ppa).
PE20211095A1 (es) Composiciones de escherichia coli y metodos de estas
MX2010003719A (es) Vacuna de mycoplasma bovis y metodos de uso de la misma.
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
PH12018502120A1 (en) Live attenuated alphavirus constructs and methods and uses thereof
AU2013370982C1 (en) Immunogenic composition comprising mycoplasma antigens
AR008491A1 (es) Vacuna contra la micosis, procedimiento para su preparacion y su uso para la profilaxis y/o el tratamiento de la micosis
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas
DE60135318D1 (de) Rekombinante bcg-impfstoffe gegen intrazelluläre pathogene und anwendungsverfahren
BR112023021812A2 (pt) Composição vacinal adjuvantada e métodos
NZ591188A (en) West nile virus vaccine
BR112024001911A2 (pt) Vacinas de rna
BR112022010228A2 (pt) Vacinas de parasita de leishmania viva atenuada com características de segurança aumentadas
MX2021015155A (es) Polisacaridos de ramnosa.
BR112022023261A2 (pt) Imunização bacteriana usando vacina de nanopartícula